scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00392-011-0383-3 |
P698 | PubMed publication ID | 22102100 |
P50 | author | Johann Wojta | Q37839061 |
Bernhard Richter | Q48970824 | ||
P2093 | author name string | Gerlinde Zorn | |
Thomas Binder | |||
Jutta Bergler-Klein | |||
Marianne Gwechenberger | |||
Heinz D Gössinger | |||
Manfred Marx | |||
Sulaima Albinni | |||
Ariel Socas | |||
P2860 | cites work | Acute-phase proteins and other systemic responses to inflammation | Q28296941 |
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up | Q28305515 | ||
Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction. | Q33720841 | ||
Adverse effects of corticosteroids on the cardiovascular system | Q33902040 | ||
Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis | Q34472307 | ||
The effect of CAPE on lipid peroxidation and nitric oxide levels in the plasma of rats following thermal injury. | Q34546296 | ||
Oxidized low-density lipoprotein-induced apoptosis | Q35047186 | ||
Is atrial fibrillation an inflammatory disorder? | Q36309624 | ||
Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction | Q36370540 | ||
Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease | Q36663530 | ||
Oxidative stress and anti-oxidative mobilization in burn injury | Q36955628 | ||
Protracted CRP elevation after atrial fibrillation ablation | Q37000988 | ||
Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? | Q37531578 | ||
Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. | Q37727983 | ||
Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial | Q42857051 | ||
Changes in the tissue and plasma superoxide dismutase (SOD) levels in a burned rat model | Q43587464 | ||
The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation | Q44351940 | ||
Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes | Q46105858 | ||
Protective effect of trapidil against oxidative organ damage in burn injury. | Q46553414 | ||
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction | Q47191457 | ||
Limitation of infarct size and attenuation of myeloperoxidase activity by an endothelin A receptor antagonist following ischaemia and reperfusion | Q47200558 | ||
[The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism]. | Q50489809 | ||
Alterations of acute phase reaction and cytokine production in patients following severe burn injury. | Q54338226 | ||
Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. | Q54440608 | ||
Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction | Q57414540 | ||
Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients | Q58050142 | ||
Concentration of Mn-superoxide dismutase in serum in acute myocardial infarction | Q70118360 | ||
Oxidative stress after moderate to extensive burning in humans | Q73967030 | ||
Upregulation of Vascular Extracellular Superoxide Dismutase in Patients With Acute Coronary Syndromes | Q79236983 | ||
Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation | Q79438250 | ||
Systemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilization | Q80868914 | ||
Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock | Q81307125 | ||
[Guidelines for catheter ablation] | Q81484409 | ||
Oxidative stress: a possible pathogenesis of atrial fibrillation | Q83063828 | ||
In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis | Q83351538 | ||
Serum levels of interleukin-6, interleukin-10 and C-reactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up | Q84039224 | ||
Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation | Q84135442 | ||
Time to rheology in acute myocardial infarction: inflammation and erythrocyte aggregation as a consequence and not necessarily as precursors of the disease | Q84232429 | ||
Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome | Q84692215 | ||
P433 | issue | 3 | |
P921 | main subject | Atrial Fibrillation | Q815819 |
P304 | page(s) | 217-225 | |
P577 | publication date | 2011-11-19 | |
P1433 | published in | Clinical Research in Cardiology | Q2665050 |
P1476 | title | Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation | |
P478 | volume | 101 |
Q39415269 | Atrial arrhythmias in obstructive sleep apnea: underlying mechanisms and implications in the clinical setting. |
Q38300328 | Atrial fibrillation and long-term sports practice: epidemiology and mechanisms |
Q38076111 | Atrial fibrillation in the elderly: the potential contribution of reactive oxygen species |
Q35805412 | Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy |
Q46833445 | Characterization of cardiac oxidative stress levels in patients with atrial fibrillation |
Q28084033 | Colchicine in prevention of atrial fibrillation following cardiac surgery: systematic review and meta-analysis |
Q47199392 | Effect of corticosteroids on atrial fibrillation after catheter ablation: a meta-analysis |
Q36047754 | Fibrosis in Atrial Fibrillation - Role of Reactive Species and MPO. |
Q96955190 | Highly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by Hypertension |
Q86476757 | Impact of real-time contact force and impedance measurement in pulmonary vein isolation procedures for treatment of atrial fibrillation |
Q51089631 | Impact of respiration gating on image integration guided atrial fibrillation ablation. |
Q44313357 | Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation |
Q38333088 | Inflammation and the pathogenesis of atrial fibrillation. |
Q34774244 | Mitochondrial DNA 4977bp deletion mutation in peripheral blood reflects atrial remodeling in patients with non-valvular atrial fibrillation |
Q55059334 | Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation. |
Q87307524 | Overweight is associated with improved survival and outcomes in patients with atrial fibrillation |
Q37151289 | Oxidized Low-density Lipoprotein (ox-LDL) Cholesterol Induces the Expression of miRNA-223 and L-type Calcium Channel Protein in Atrial Fibrillation |
Q35851738 | Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation |
Q28486285 | The association between heme oxygenase-1 gene promoter polymorphism and the outcomes of catheter ablation of atrial fibrillation |
Q87334615 | The year in clinical research in cardiology: the official journal of the German Cardiac Society (Deutsche Gesellschaft für Kardiologie--Herz- und Kreislaufforschung) |
Q42359536 | What Does The Blanking Period Blank? |
Q88673560 | [Biomarkers and atrial fibrillation : Prediction of recurrences and thromboembolic events after rhythm control management] |
Search more.